| |
|
|
| |
| |
Results
| The following outlines a summary of the
UNLOAD study. For complete study results, use the links below
to request copies of supporting materials.
Results of UNLOAD clinical study published in the February 13, 2007, edition of the Journal of American College of Cardiology (JACC), show that hospitalized heart failure patients receiving a simplified form of ultrafiltration therapy as part of their care lost more weight, experienced greater net fluid loss, and had fewer rehospitalizations than patients treated primarily with intravenous diuretics.
The UNLOAD clinical trial is the first randomized study to compare the safety and efficacy of a non-drug-based option with standard intravenous diuretic drug therapy to treat heart failure patients. Heart failure, a progressive and debilitating disease, leads to more than 1 million hospital admissions and over $29 billion in healthcare costs annually in the United States.
To request a free
reprint of the UNLOAD study and editorial published in JACC,
click here. |
|
To view or download powerpoint slides about the
UNLOAD study, click on your choice below.
|
 |
|
|
|
|
| |
This site sponsored by CHF Solutions, Inc. Click here to learn more
about
Aquapheresis® Therapy using Aquadex FlexFlow®. |
|
|
|
|
|
|
|
 |
 |
 |
